A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma

Figure 6

Gene set enrichment analysis. (a) and (b) Hallmark analysis of the two risk groups. (c) and (d) KEGG analysis of the two risk groups.